BeOne Medicines AG (ONC) Stock Overview
Explore BeOne Medicines AG’s financial performance, market position, analyst ratings, and future outlook.
BeOne Medicines AG (ONC)
Key Financials
Key Financials
Market Cap
34.1B
P/E Ratio
6.44
EPS (TTM)
$4.47
ROE
0.12%
ONC Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of BeOne Medicines AG (ONC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 67.25, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $358.67.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 6.44 and a market capitalization of 34.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.